Option Care Health, Inc. Common Stock(OPCH)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $18.01 – $36.80
- YTD
- -35.61%
- IV Rank (30D)
- 58.18
- Straddle Price
- $2.28
- P/C Vol Ratio
- 0.12
- Market Cap
- $3.3B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.53% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.03% (VRP-adj) |
| WACC | 8.51% |
| Volatility Risk Premium | +38.4pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 26.5% |
| Rev. Growth (YoY, DCF input) | -4.6% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | 15.3% |
| Book / Price | 40.1% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 19.2% |
| FCF Margin (TTM) | 3.8% |
| Debt / Equity | 0.85 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +6.7% (reverse-DCF on current price) |
| SMA 50 | $23.67 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $20.78 |
| Bollinger Width / SMA20 | 64.2% (drives anchor stability) |
| Net Debt | $1.0B |
| Market Cap | $3B |
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -1.0% ⚠ | +0.61 | +0.31 | 46.1% | — |
| 42d | -2.4% ⚠ | +0.49 | +0.25 | 41.0% | — |
| 63d | -2.7% ⚠ | +0.38 | +0.20 | 37.3% | — |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $10.24 | 27% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $38.84 | 12% | median 30.3× · 4 peers |
| Peer EV/EBITDA | $41.13 | 12% | median 19.1× · 5 peers |
| Peer P/B | $19.66 | 2% | median 2.4× · 5 peers |
| Peer P/S | $15.37 | 8% | median 0.4× · 5 peers |
| Market Anchor (SMA50) | $23.67 | 38% | stability 69% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SERVICES-HOME HEALTH CARE SERVICES (8082)
- Exchange
- XNAS
- Market Cap
- $3.3B
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +4.67% | 6 |
| Feb | +2.47% | 7 |
| Mar | -5.27% | 7 |
| Apr | +3.73% | 7 |
| May | -0.14% | 7 |
| Jun | +1.69% | 7 |
| Jul | +0.51% | 6 |
| Aug | +4.53% | 6 |
| Sep | -0.41% | 6 |
| Oct | -6.82% | 6 |
| Nov | +6.27% | 6 |
| Dec | +3.02% | 6 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-07-31 | Pre-Market | 9.09% | 3.70% | 0.41x | Within |
| 2024-10-30 | Pre-Market | 8.03% | 22.62% | 2.82x | Exceeded |
| 2025-02-26 | Pre-Market | 13.36% | 9.33% | 0.70x | Within |
| 2025-04-29 | Pre-Market | 11.30% | 6.56% | 0.58x | Within |
| 2025-07-30 | Pre-Market | 9.13% | 1.69% | 0.19x | Within |
| 2025-10-30 | Pre-Market | 13.52% | 8.60% | 0.64x | Within |
| 2026-02-24 | Pre-Market | 10.48% | 6.21% | 0.59x | Within |
| 2026-04-30 | Pre-Market | 13.96% | 24.71% | 1.77x | Exceeded |
- IV Rank (30D)
- 58.18
- IV Rank (7D)
- 100
- Avg IV
- 124.7%
- Straddle (30D)
- $2.28
- Straddle (7D)
- $1.27
- P/C Volume
- 0.12
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 0.29
- Correlation (SPY)
- 8.7%
- R²
- 0.01
- Ann. Volatility
- 40.8%
- SPY Volatility
- 12.3%
Low volatility - stock moves less than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC Custodian | $24.14M | 63.63% | 2026-03-31 |
| 2 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $2.39M | 6.31% | 2026-03-31 |
| 3 | JANE STREET GROUP, LLC Custodian | $2.18M | 5.73% | 2026-03-31 |
| 4 | MILLENNIUM MANAGEMENT LLC Custodian | $1.88M | 4.97% | 2026-03-31 |
| 5 | IMC-Chicago, LLC Custodian | $1.87M | 4.92% | 2026-03-31 |
| 6 | Walleye Trading LLC | $1.68M | 4.42% | 2026-03-31 |
| 7 | GROUP ONE TRADING LLC Custodian | $1.48M | 3.90% | 2026-03-31 |
| 8 | Crawford Fund Management, LLC | $1.08M | 2.86% | 2026-03-31 |
| 9 | Walleye Capital LLC | $600.32K | 1.58% | 2026-03-31 |
| 10 | Twin Tree Management, LP | $374.19K | 0.99% | 2026-03-31 |
| 11 | WOLVERINE TRADING, LLC Custodian | $206.55K | 0.54% | 2025-09-30 |
| 12 | SIMPLEX TRADING, LLC Custodian | $56.53K | 0.15% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $891.05K | 32.68% | 2026-03-31 |
| 2 | CSS LLC/IL | $538.40K | 19.74% | 2026-03-31 |
| 3 | IMC-Chicago, LLC Custodian | $484.56K | 17.77% | 2026-03-31 |
| 4 | CITADEL ADVISORS LLC Custodian | $471.10K | 17.28% | 2026-03-31 |
| 5 | Walleye Capital LLC | $333.81K | 12.24% | 2026-03-31 |
| 6 | Walleye Trading LLC | $5.38K | 0.20% | 2026-03-31 |
| 7 | SIMPLEX TRADING, LLC Custodian | $2.69K | 0.10% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | ERIC BRANDT | Director | Award (A) | +11,640 | $22.23 | $58.8K | EDGAR |
| 2026-05-22 | Norman L. Wright | Director | Award (A) | +8,997 | — | EDGAR | |
| 2026-05-22 | Barbara W. Bodem | Director | Award (A) | +8,997 | — | EDGAR | |
| 2026-05-22 | TIMOTHY P SULLIVAN | Director | Award (A) | +13,833 | $22.23 | $107.5K | EDGAR |
| 2026-05-22 | R Carter Pate | Director | Award (A) | +8,997 | — | EDGAR | |
| 2026-05-22 | HARRY M JANSEN JR KRAEMER | Director | Award (A) | +21,076 | $22.23 | $268.5K | EDGAR |
| 2026-05-22 | Natasha Deckmann | Director | Award (A) | +9,841 | $22.23 | $18.8K | EDGAR |
| 2026-05-22 | Elizabeth D Bierbower | Director | Award (A) | +8,997 | — | EDGAR | |
| 2026-05-21 | Collin Smyser | GC & Corporate Secretary | Mixed | +452 | $20.86 | -$7.5K | EDGAR |
| 2026-05-07 | TIMOTHY P SULLIVAN | Director | Buy (P) | +24,154 | $20.69 | $499.7K | EDGAR |
| 2026-05-05 | HARRY M JANSEN JR KRAEMER | Director | Buy (P) | +36,610 | $21.41 | $783.8K | EDGAR |
| 2026-05-04 | JOHN CHARLES RADEMACHER | Chief Executive Officer | Buy (P) | +12,500 | $21.18 | $264.7K | EDGAR |
| 2026-05-04 | Meenal Sethna | Chief Financial Officer | Buy (P) | +16,225 | $20.16 | $327.1K | EDGAR |
| 2026-04-24 | Femi Adewunmi | Chief Medical Officer | Tax (F) | −1,396 | $28.38 | -$39.6K | EDGAR |
| 2026-03-03 | Michael Bavaro | Chief Human Resources Officer | Sell (S) | −6,000 | $33.00 | -$198.0K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | SAMUEL M MENCOFF | Director | 47,160,171 | $979.05M | -$2.93B | 1 | 2021-08-06 |
| 2 | MADISON DEARBORN PARTNERS VI-A&C, L.P. | Director | 37,960,171 | $788.05M | -$1.73B | 1 | 2021-09-10 |
| 3 | PAUL J FINNEGAN | Director | 37,341,872 | $775.22M | $0 | 1 | 2021-09-21 |
| 4 | OCH US Holding LLC | 10%+ Owner | 10,771,926 | $223.63M | -$4.16B | 2 | 2023-03-03 |
| 5 | JOHN CHARLES RADEMACHER | Chief Executive Officer | 695,152 | $14.43M | $428.9K | 18 | 2026-05-04 |
| 6 | HARRY M JANSEN JR KRAEMER | Director | 458,997 | $9.53M | $8.50M | 16 | 2026-05-22 |
| 7 | MICHAEL H. SHAPIRO | Chief Financial Officer | 311,933 | $6.48M | -$677.7K | 14 | 2025-02-26 |
| 8 | Luke Whitworth | Chief Operating Officer | 169,589 | $3.52M | $0 | 13 | 2026-02-26 |
| 9 | DAVID W GOLDING | Director | 116,525 | $2.42M | $27.6K | 8 | 2025-08-21 |
| 10 | RICHARD DENNESS | Chief Commercial Officer | 111,734 | $2.32M | $0 | 6 | 2023-03-13 |
| 11 | Meenal Sethna | Chief Financial Officer | 98,337 | $2.04M | $327.1K | 3 | 2026-05-04 |
| 12 | TIMOTHY P SULLIVAN | Director | 87,216 | $1.81M | -$1.86B | 21 | 2026-05-22 |
| 13 | Harriet Booker | CHIEF OPERATING OFFICER | 86,760 | $1.80M | -$1.29M | 11 | 2022-06-08 |
| 14 | Collin Smyser | GC & Corporate Secretary | 77,512 | $1.61M | $86.7K | 15 | 2026-05-21 |
| 15 | JOHN ARLOTTA | Director | 71,009 | $1.47M | $0 | 5 | 2024-05-17 |
| 16 | Nitin Sahney | Director | 61,657 | $1.28M | $0 | 4 | 2023-06-07 |
| 17 | MADISON DEARBORN PARTNERS LLC | Director | 56,995 | $1.18M | $0 | 1 | 2021-11-15 |
| 18 | Madison Dearborn Capital Partners VI-A, L.P. | Director | 56,994 | $1.18M | -$1.74B | 3 | 2021-12-20 |
| 19 | Christopher L. Grashoff | Chief Growth Officer | 44,092 | $915.3K | $0 | 11 | 2026-02-26 |
| 20 | Michael Bavaro | Chief Human Resources Officer | 33,249 | $690.2K | -$1.67M | 17 | 2026-03-03 |
| 21 | Elizabeth D Bierbower | Director | 32,871 | $682.4K | $79.1K | 6 | 2026-05-22 |
| 22 | Natasha Deckmann | Director | 32,002 | $664.4K | $0 | 5 | 2026-05-22 |
| 23 | ELIZABETH QUADROS BETTEN | Director | 29,216 | $606.5K | -$1.87B | 18 | 2025-05-19 |
| 24 | Nicole Maggio | Chief Accounting Officer | 28,489 | $591.4K | $0 | 8 | 2026-02-26 |
| 25 | Femi Adewunmi | Chief Medical Officer | 25,314 | $525.5K | $0 | 6 | 2026-04-24 |
| 26 | Norman L. Wright | Director | 24,498 | $508.6K | $100.0K | 5 | 2026-05-22 |
| 27 | ERIC BRANDT | Director | 21,999 | $456.7K | $0 | 3 | 2026-05-22 |
| 28 | Barbara W. Bodem | Director | 21,087 | $437.8K | $0 | 4 | 2026-05-22 |
| 29 | R Carter Pate | Director | 20,620 | $428.1K | -$1.37M | 18 | 2026-05-22 |
| 30 | Clifford E Berman | SEE REMARKS | 5,272 | $109.4K | $0 | 1 | 2021-07-13 |
| 31 | Robert R Kampstra | CHIEF ACCOUNTING OFFICER | 2,504 | $52.0K | $0 | 1 | 2021-07-13 |
| 32 | ALAN TROY NIELSEN | Director | 2,000 | $41.5K | $25.1K | 1 | 2020-05-13 |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-22 | 0001014739-26-000017 | EDGAR |
| 2026-05-12 | 0001104659-26-058979 | EDGAR |
| 2026-05-05 | 0001014739-26-000014 | EDGAR |
| 2026-04-30 | 0001104659-26-052099 | EDGAR |
| 2026-04-02 | 0001104659-26-039171 | EDGAR |
| 2026-02-24 | 0001014739-26-000005 | EDGAR |
| 2026-01-12 | 0001104659-26-002887 | EDGAR |
| 2025-10-30 | 0001014739-25-000043 | EDGAR |
| 2025-09-25 | 0001104659-25-093337 | EDGAR |
| 2025-08-20 | 0001104659-25-080912 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-24 | 0001014739-26-000008 | EDGAR |
| 2025-02-26 | 0001014739-25-000012 | EDGAR |
| 2024-02-22 | 0001014739-24-000009 | EDGAR |
| 2023-02-23 | 0001014739-23-000009 | EDGAR |
| 2022-02-23 | 0001014739-22-000009 | EDGAR |
| 2021-03-11 | 0001014739-21-000011 | EDGAR |
| 2020-03-05 | 0001014739-20-000013 | EDGAR |
| 2019-03-15 | 0001014739-19-000012 | EDGAR |
| 2018-03-26 | 0001628280-18-003541 | EDGAR |
| 2017-03-07 | 0001628280-17-002304 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-30 | 0001014739-26-000011 | EDGAR |
| 2025-10-30 | 0001014739-25-000046 | EDGAR |
| 2025-07-30 | 0001014739-25-000037 | EDGAR |
| 2025-04-29 | 0001014739-25-000022 | EDGAR |
| 2024-10-30 | 0001014739-24-000052 | EDGAR |
| 2024-07-31 | 0001014739-24-000035 | EDGAR |
| 2024-04-23 | 0001014739-24-000022 | EDGAR |
| 2023-10-25 | 0001014739-23-000042 | EDGAR |
| 2023-07-27 | 0001014739-23-000034 | EDGAR |
| 2023-05-04 | 0001014739-23-000019 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 16.2 |
| P/B Ratio | 2.4 |
| P/S Ratio | 0.6 |
| EV/EBITDA | 10.6 |
| TTM Revenue | $5.7B |
| TTM Net Income | $0.2B |
| TTM EPS | $1.28 |
| ROE | 15.3% |
| Debt/Equity | 0.86 |